About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Tata India Pharma & Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSUN PHARMACEUTICAL INDUSTRIES LTD12.8021854300156.5334
Domestic EquitiesCIPLA LTD6.212049000075.9549
Domestic EquitiesAUROBINDO PHARMA LTD6.183161510075.6019
Domestic EquitiesAPOLLO HOSPITALS ENTERPRISE LTD5.777710125570.6456
Domestic EquitiesDIVI LABORATORIES LTD5.225410496563.8922
Domestic EquitiesLUPIN LTD5.197230324063.5470
Domestic EquitiesFORTIS HEALTHCARE LTD4.794385510058.6214
Domestic EquitiesASTER DM HEALTHCARE LTD3.952195699148.3233
Domestic EquitiesALKEM LABORATORIES LTD3.14857524938.4974
Domestic EquitiesHEALTHCARE GLOBAL ENTERPRISES LTD3.064166612137.4660
Domestic EquitiesDR REDDYS LABORATORIES LTD3.016631155536.8850
Domestic EquitiesWOCKHARDT LTD2.915027487135.6425
Domestic EquitiesLAURUS LABS LTD2.247145500027.4752
Domestic EquitiesAJANTA PHARMA LTD2.09679473725.6368
Domestic EquitiesTORRENT PHARMACEUTICALS LTD1.92687092123.5600
Domestic EquitiesMETROPOLIS HEALTHCARE LTD1.901413663623.2486
Domestic EquitiesKRISHNA INSTITUTE OF MEDICAL SCIENCES LTD1.759132745221.5087
Domestic EquitiesDR. LAL PATH LABS LTD1.65807321120.2729
Domestic EquitiesIPCA LABORATORIES LTD1.632514245219.9604
Domestic EquitiesFDC LTD1.622747128319.8410
Domestic EquitiesMEDI ASSIST HEALTHCARE SERVICES LTD1.536941867018.7920
Domestic EquitiesDR. AGARWALS HEALTH CARE LTD1.358445518716.6098
Domestic EquitiesJUPITER LIFE LINE HOSPITALS LTD1.277010638915.6136
Domestic EquitiesINDOCO REMEDIES LTD1.268766699215.5122
Domestic EquitiesAKUMS DRUGS AND PHARMACEUTICALS LTD1.099125735213.4389
Domestic EquitiesCOROMANDEL INTERNATIONAL LTD1.08656000013.2852
Domestic EquitiesZYDUS LIFESCIENCES LTD0.997313728712.1945
Domestic EquitiesSANOFI INDIA LTD0.93151916411.3892
Domestic EquitiesAMI ORGANICS LTD0.924710000011.3060
Domestic EquitiesMANKIND PHARMA LTD0.83574144610.2177
Domestic EquitiesMEDPLUS HEALTH SERVICES LTD0.78331188089.5777
Domestic EquitiesSANOFI CONSUMER HEALTHCARE INDIA LTD0.7743191649.4670
Domestic EquitiesORCHID PHARMA LTD0.75341150009.2115
Domestic EquitiesPROCTER & GAMBLE HEALTH LTD0.6650160008.1312
Domestic EquitiesGLAXOSMITHKLINE PHARMACEUTICALS LTD0.5962245887.2894
Domestic EquitiesSYNGENE INTERNATIONAL LTD0.55511070466.7873
Domestic EquitiesINVENTURUS KNOWLEDGE SOLUTIONS LTD0.5040417426.1620
Domestic EquitiesDEEPAK NITRITE LTD0.2835179093.4665
Domestic EquitiesLAXMI DENTAL LTD0.0460143570.5623
Total 93.4087 1142.1282
Cash & Cash Equivalents and Net AssetsCASH / NET CURRENT ASSET6.3711 77.9003
Cash & Cash Equivalents and Net AssetsA) REPO0.2202 2.6925
Total 6.5913 80.5928
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.